ReNeuron Group plc
RENE.L · LSE
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£2,841 | -£2,232 | -£3,176 | -£4,455 |
| Dep. & Amort. | £129 | £135 | £132 | £148 |
| Deferred Tax | £0 | £0 | -£987 | £0 |
| Stock-Based Comp. | £205 | £206 | £185 | £94 |
| Change in WC | £163 | -£29 | -£538 | £201 |
| Other Non-Cash | £243 | -£1,241 | £93 | £1,412 |
| Operating Cash Flow | -£2,101 | -£3,161 | -£4,291 | -£2,789 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | -£64 | -£156 | -£64 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £1,110 | £4,099 | £2,016 | £1,262 |
| Investing Cash Flow | £1,110 | £4,035 | -£156 | -£64 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £2 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£76 | -£4,081 | £3,934 | -£786 |
| Financing Cash Flow | -£76 | -£4,081 | £3,934 | £929 |
| Forex Effect | -£11 | -£104 | £215 | £27 |
| Net Chg. in Cash | -£1,078 | -£9,464 | -£84 | -£1,870 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £6,153 | £9,464 | £9,548 | £11,418 |
| End Cash | £5,075 | £0 | £9,464 | £9,548 |
| Free Cash Flow | -£2,101 | -£3,225 | -£4,447 | -£2,853 |